13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0000902664-25-002321
Total Value
$73.0M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,664,548 | $45.8M | 62.72% |
| 2 | TG THERAPEUTICS INC | TGTX | 161,600 | $6.4M | 8.73% |
| 3 | INVIVYD INC | IVVD | 9,248,250 | $5.6M | 7.67% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $4.2M | 5.74% |
| 5 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $2.6M | 3.53% |
| 6 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 55,200 | $2.4M | 3.34% |
| 7 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $2.2M | 3.03% |
| 8 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $1.4M | 1.86% |
| 9 | CURIS INC | CRIS | 521,059 | $1.1M | 1.50% |
| 10 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $858,676 | 1.18% |
| 11 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $521,982 | 0.72% |